Antihypertensive drugs and risk of COVID-19?

Lancet Respir Med. 2020 May;8(5):e28. doi: 10.1016/S2213-2600(20)30158-2. Epub 2020 Mar 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antihypertensive Agents
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections
  • Diabetes Mellitus*
  • Humans
  • Hypertension*
  • Pandemics
  • Pneumonia, Viral
  • SARS-CoV-2

Substances

  • Antihypertensive Agents